Protagonist Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.

About PTGX

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943.

CEO

Dinesh V. Patel

CEODinesh V. Patel

Employees

126

Employees126

Headquarters

Newark, California

HeadquartersNewark, California

Founded

2006

Founded2006

Employees

126

Employees126

PTGX Key Statistics

Market cap

2.75B

Market cap2.75B

Price-Earnings ratio

58.38

Price-Earnings ratio58.38

Dividend yield

—

Dividend yield—

Average volume

883.78K

Average volume883.78K

High today

$45.19

High today$45.19

Low today

$44.11

Low today$44.11

Open price

$44.35

Open price$44.35

Volume

137.92K

Volume137.92K

52 Week high

$60.60

52 Week high$60.60

52 Week low

$27.00

52 Week low$27.00

PTGX News

Simply Wall St 4d

Protagonist Therapeutics Insiders Sold US$5.1m Of Shares Suggesting Hesitancy

Many Protagonist Therapeutics, Inc. ( ) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When analyzing...

Analyst ratings

91%

of 11 ratings

Buy

90.9%

Hold

9.1%

Sell

People also own

Based on the portfolios of people who own PTGX. This list is generated using Robinhood data, and it’s not a recommendation.